The Oncology / Hematology Channel
01:22 | Oncology / Hematology
This session focused on patient-reported outcomes for Paroxysmal Nocturnal Hemoglobinuria (PNH) and how the disease and current treatments affect patient lives. A key highlight was a Ukrainian patient’s story, illustrating the real-world impact of PNH. The discussion highlighted how C5 inhibitors have improved patient outcomes but emphasized that real-world data often differs from trial data due to longer follow-ups and varied patient populations. The session stressed the importance of understanding treatment effectiveness and the role of patient choice in improving outcomes.